Characteristics | Non-DKD | DKD | P value |
---|---|---|---|
Age, years | 66 ± 6 | 67 ± 8 | <0.001 |
Men, % | 532(42%) | 377(48.1%) | 0.007 |
BMI, kg/m2 | 25.31 ± 4.10 | 26.70 ± 5.41 | <0.001 |
Duration of diabetes, years | 16 ± 12 | 18 ± 15 | <0.001 |
SBP, mmHg | 138 ± 19 | 137 ± 20 | 0.001 |
DBP, mmHg | 78 ± 15 | 78 ± 15 | 0.924 |
25-OH-D, nmol/L | 17.31 ± 10.46 | 15.40 ± 9.54 | <0.001 |
β-CTX, ng/mL | 0.35 ± 0.24 | 0.336 ± 0.25 | 0.077 |
OSTEOC, ng/L | 11.26 ± 5.45 | 10.48 ± 5.40 | 0.017 |
iPTH, pg/ml | 34.00 ± 17.20 | 34.30 ± 22.75 | 0.013 |
TP1NP, µg/L | 39.25 ± 21.26 | 38.64 ± 24.65 | 0.808 |
FPG, mmol/L | 11.12 ± 6.99 | 11.125 ± 7.49 | <0.001 |
HbA1c, % | 8.00 ± 2.20 | 8.50 ± 2.90 | <0.001 |
TC, mmol/L | 4.33 ± 1.55 | 4.53 ± 1.81 | 0.330 |
TG, mmol/L | 1.39 ± 0.94 | 1.54 ± 0.87 | <0.001 |
HDL, mmol/L | 1.16 ± 0.34 | 1.12 ± 0.30 | <0.001 |
LDL, mmol/L | 2.69 ± 1.16 | 2.93 ± 1.32 | 0.183 |
ALT, U/L | 18.10 ± 11.40 | 17.75 ± 11.32 | 0.002 |
AST, U/L | 19.30 ± 8.13 | 18.85 ± 7.80 | 0.344 |
ALP, U/L | 80.0 ± 33.00 | 83.50 ± 34.75 | 0.030 |
ALB, g/L | 43.20 ± 3.72 | 41.15 ± 4.50 | <0.001 |
Hemoglobin, g/L | 138 ± 19 | 131 ± 21 | <0.001 |
Serum calcium, mmol/L | 2.395 ± 0.12 | 2.38 ± 0.14 | <0.001 |
Serum phosphorus, mmol/L | 1.15 ± 0.21 | 1.18 ± 0.26 | 0.636 |
Serum creatinine, umol/L | 62 ± 21 | 77.95 ± 40.75 | <0.001 |
Serum uric acid, umol/L | 310 ± 114.5 | 341.5 ± 131.75 | <0.001 |
UACR, mg/g | 9.16 ± 8.74 | 94.84 ± 303.53 | <0.001 |
eGFR, mL/min per 1.73 m2 | 95.64 ± 17.80 | 80.73 ± 38.38 | <0.001 |
Medications | Â | Â | Â |
   ACEI/ARB, % | 1061(84.2%) | 718(91.6%) | <0.001 |
   Anti-osteoporosis drugs, % | 820(64.7%) | 487(62.1%) | 0.234 |
   Anti-diabetic agents, % | 350(27.6%) | 321(40.9%) | <0.001 |
Diabetic retinopathy | 177(14.0%) | 520(66.3%) | <0.001 |